(Q45856623)

17 December 2017

title

Clinical guidelines for treating von Willebrand disease patients who are not candidates for DDAVP--a survey of European physicians (English)

1 reference

17 December 2017

1

Lusher JM

1 reference

17 December 2017

publication date

1 January 1998

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

4 Suppl 3

1 reference

17 December 2017

page(s)

11-14

1 reference

17 December 2017

Replacement Therapy with Virus-Inactivated Plasma Concentrates in von Willebrand Disease

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3011.X

Therapy of von Willebrand disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3011.X

von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3011.X

Laboratory assessment of von Willebrand factor. Use of different assays can influence the diagnosis of von Willebrand's disease, dependent on differing sensitivity to sample preparation and differential recognition of high molecular weight VWF forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.0040S3011.X

10.1046/J.1365-2516.1998.0040S3011.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017